Leandro José Bertoglio - Publications

Affiliations: 
1999-2004 Pharmacology Universidade Federal de Santa Catarina (UFSC) 

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lisboa SF, Stern CAJ, Gazarini L, Bertoglio LJ. Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies. International Review of Neurobiology. 177: 235-250. PMID 39029986 DOI: 10.1016/bs.irn.2024.03.007  0.548
2024 Soares LA, Nascimento LMM, Guimarães FS, Gazarini L, Bertoglio LJ. Dual-step pharmacological intervention for traumatic-like memories: implications from D-cycloserine and cannabidiol or clonidine in male and female rats. Psychopharmacology. PMID 38691149 DOI: 10.1007/s00213-024-06596-8  0.436
2024 Werle I, Nascimento LMM, Dos Santos ALA, Soares LA, Dos Santos RG, Hallak JEC, Bertoglio LJ. Ayahuasca-enhanced extinction of fear behaviour: Role of infralimbic cortex 5-HT and 5-HT receptors. British Journal of Pharmacology. PMID 38320596 DOI: 10.1111/bph.16315  0.329
2023 Gazarini L, Stern CAJ, Bertoglio LJ. On making (and turning adaptive to) maladaptive aversive memories in laboratory rodents. Neuroscience and Biobehavioral Reviews. 147: 105101. PMID 36804263 DOI: 10.1016/j.neubiorev.2023.105101  0.446
2022 Iglesias LP, Fernandes HB, de Miranda AS, Perez MM, Faccioli LH, Sorgi CA, Bertoglio LJ, Aguiar DC, Wotjak CT, Moreira FA. TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus. Neuropharmacology. 109314. PMID 36336070 DOI: 10.1016/j.neuropharm.2022.109314  0.486
2022 Franzen JM, Werle I, Vanz F, de Oliveira BB, Martins Nascimento LM, Guimarães FS, Bertoglio LJ. Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT but not CB1 or CB2 receptors. Neuropharmacology. 109316. PMID 36334768 DOI: 10.1016/j.neuropharm.2022.109316  0.474
2022 Franzen JM, Vanz F, Werle I, Guimarães FS, Bertoglio LJ. Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 64: 7-18. PMID 36049316 DOI: 10.1016/j.euroneuro.2022.08.002  0.512
2021 Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology. 205: 108913. PMID 34864001 DOI: 10.1016/j.neuropharm.2021.108913  0.676
2021 Gazarini L, Stern CA, Takahashi RN, Bertoglio LJ. Interactions of Noradrenergic, Glucocorticoid and Endocannabinoid Systems Intensify and Generalize Fear Memory Traces. Neuroscience. PMID 34560200 DOI: 10.1016/j.neuroscience.2021.09.012  0.475
2020 Troyner F, Bertoglio LJ. Nucleus reuniens of the thalamus controls fear memory reconsolidation. Neurobiology of Learning and Memory. 177: 107343. PMID 33242589 DOI: 10.1016/j.nlm.2020.107343  0.51
2020 Rodrigues JVF, Vidigal APP, Minassa VS, Batista TJ, de Lima RMS, Funck VR, Antero LS, Resstel LBM, Coitinho JB, Bertoglio LJ, Sampaio KN, Beijamini V. A single dose of the organophosphate triazophos induces fear extinction deficits accompanied by hippocampal acetylcholinesterase inhibition. Neurotoxicology and Teratology. 106929. PMID 33031921 DOI: 10.1016/j.ntt.2020.106929  0.423
2020 Marin FN, Franzen JM, Troyner F, Molina VA, Giachero M, Bertoglio LJ. Taking advantage of fear generalization-associated destabilization to attenuate the underlying memory via reconsolidation intervention. Neuropharmacology. 181: 108338. PMID 33002500 DOI: 10.1016/j.neuropharm.2020.108338  0.414
2020 Bayer H, Bertoglio LJ. Infralimbic cortex controls fear memory generalization and susceptibility to extinction during consolidation. Scientific Reports. 10: 15827. PMID 32985565 DOI: 10.1038/s41598-020-72856-0  0.668
2020 Troyner F, Bertoglio LJ. Thalamic nucleus reuniens regulates fear memory destabilization upon retrieval. Neurobiology of Learning and Memory. 175: 107313. PMID 32956808 DOI: 10.1016/J.Nlm.2020.107313  0.607
2020 Raymundi AM, da Silva TR, Sohn JMB, Bertoglio LJ, Stern CA. Effects of ∆-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies. Bmc Psychiatry. 20: 420. PMID 32842985 DOI: 10.1186/S12888-020-02813-8  0.515
2020 da Silva TR, Raymundi AM, Bertoglio LJ, Andreatini R, Stern CA. Role of prelimbic cortex PKC and PKMζ in fear memory reconsolidation and persistence following reactivation. Scientific Reports. 10: 4076. PMID 32139711 DOI: 10.1038/S41598-020-60046-X  0.563
2019 Raymundi AM, da Silva TR, Zampronio AR, Guimarães FDS, Bertoglio LJ, Stern CAJ. A time-dependent contribution of hippocampal CB1, CB2, and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation. British Journal of Pharmacology. PMID 31648363 DOI: 10.1111/Bph.14895  0.578
2019 Franzen JM, Giachero M, Bertoglio LJ. Dissociating retrieval-dependent contextual aversive memory processes in female rats: Are there cycle-dependent differences? Neuroscience. 406: 542-553. PMID 30935981 DOI: 10.1016/J.Neuroscience.2019.03.035  0.535
2019 Lisboa SF, Vila-Verde C, Rosa J, Uliana DL, Stern CAJ, Bertoglio LJ, Resstel LB, Guimaraes FS. Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies. Psychopharmacology. PMID 30604182 DOI: 10.1007/s00213-018-5127-x  0.402
2018 Troyner F, Bicca MA, Bertoglio LJ. Nucleus reuniens of the thalamus controls fear memory intensity, specificity and long-term maintenance during consolidation. Hippocampus. 28: 602-616. PMID 29747244 DOI: 10.1002/Hipo.22964  0.613
2018 Vanz F, Bicca MA, Linartevichi VF, Giachero M, Bertoglio LJ, Lima TCMd. Role of dorsal hippocampus κ opioid receptors in contextual aversive memory consolidation in rats. Neuropharmacology. 135: 253-267. PMID 29499274 DOI: 10.1016/J.Neuropharm.2018.02.029  0.586
2017 Cavalli J, Hoeller AA, Dal Bó S, Bertoglio LJ, de Lima TCM, Carobrez AP. Dexamethasone impairs encoding and expression of aversive conditioning promoted by pentylenetetrazole. Behavioural Pharmacology. PMID 28863004 DOI: 10.1097/Fbp.0000000000000344  0.465
2017 Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors. Neuropharmacology. 125: 220-230. PMID 28754373 DOI: 10.1016/J.Neuropharm.2017.07.024  0.602
2017 Stern CAJ, de Carvalho CR, Bertoglio LJ, Takahashi RN. Effects of cannabinoid drugs on aversive and rewarding drug-associated memory extinction and reconsolidation. Neuroscience. PMID 28729064 DOI: 10.1016/J.Neuroscience.2017.07.018  0.552
2017 Lee JL, Bertoglio LJ, Guimarães FS, Stevenson CW. Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. British Journal of Pharmacology. PMID 28268256 DOI: 10.1111/Bph.13724  0.552
2016 Jurkus R, Day HL, Guimarães FS, Lee JL, Bertoglio LJ, Stevenson CW. Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders. Frontiers in Pharmacology. 7: 454. PMID 27932983 DOI: 10.3389/Fphar.2016.00454  0.491
2016 Vanvossen AC, Portes MA, Scoz-Silva R, Reichmann HB, Stern CA, Bertoglio LJ. Newly acquired and reactivated contextual fear memories are more intense and prone to generalize after activation of prelimbic cortex NMDA receptors. Neurobiology of Learning and Memory. PMID 27919830 DOI: 10.1016/J.Nlm.2016.12.002  0.587
2016 da Silva TR, Takahashi RN, Bertoglio LJ, Andreatini R, Stern CA. Evidence for an expanded time-window to mitigate a reactivated fear memory by tamoxifen. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27554635 DOI: 10.1016/J.Euroneuro.2016.08.005  0.561
2016 de Morais H, de Souza CP, da Silva LM, Ferreira DM, Baggio CH, Vanvossen AC, Cristina de Carvalho M, da Silva-Santos JE, Bertoglio LJ, Cunha JM, Zanoveli JM. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27544303 DOI: 10.1016/J.Euroneuro.2016.08.007  0.338
2015 Matheus FC, Rial D, Real JI, Lemos C, Ben J, Guaita GO, Pita IR, Sequeira AC, Pereira FC, Walz R, Takahashi RN, Bertoglio LJ, Cunha CD, Cunha RA, Prediger RD. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats. Behavioural Brain Research. PMID 26707254 DOI: 10.1016/J.Bbr.2015.12.011  0.413
2015 Matheus FC, Rial D, Real JI, Lemos C, Takahashi RN, Bertoglio LJ, Cunha RA, Prediger RD. Temporal Dissociation of Striatum and Prefrontal Cortex Uncouples Anhedonia and Defense Behaviors Relevant to Depression in 6-OHDA-Lesioned Rats. Molecular Neurobiology. PMID 26164273 DOI: 10.1007/S12035-015-9330-Z  0.329
2015 Stern CA, Gazarini L, Vanvossen AC, Zuardi AW, Galve-Roperh I, Guimaraes FS, Takahashi RN, Bertoglio LJ. Δ(9)-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 958-65. PMID 25799920 DOI: 10.1016/J.Euroneuro.2015.02.001  0.603
2014 Gazarini L, Stern CA, Piornedo RR, Takahashi RN, Bertoglio LJ. PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25539509 DOI: 10.1093/Ijnp/Pyu026  0.585
2014 Stern CA, Gazarini L, Vanvossen AC, Hames MS, Bertoglio LJ. Activity in prelimbic cortex subserves fear memory reconsolidation over time. Learning & Memory (Cold Spring Harbor, N.Y.). 21: 14-20. PMID 24344180 DOI: 10.1101/Lm.032631.113  0.601
2014 Stern CA, Gazarmi L, Vanvossen AC, Zuardi AW, Guimarães FS, Takahashi RN, Bertoglio LJ. P.1.j.006 Involvement of the prelimbic cortex in the disruptive effect of cannabidiol on fear memory reconsolidation European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70511-5  0.559
2014 Gazarini L, Stern C, Takahashi R, Bertoglio L. P.1.j.001 Combined pharmacological intervention targeting the glucocorticoid–adrenergic–endocannabinoid circuitry induces a traumatic memory European Neuropsychopharmacology. 24: S319-S320. DOI: 10.1016/S0924-977X(14)70507-3  0.438
2013 Gazarini L, Stern CA, Carobrez AP, Bertoglio LJ. Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting α1- and β-adrenergic receptors. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 210-9. PMID 23512937 DOI: 10.1101/Lm.030007.112  0.537
2012 Stern CA, Gazarini L, Takahashi RN, Guimarães FS, Bertoglio LJ. On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2132-42. PMID 22549120 DOI: 10.1038/Npp.2012.63  0.588
2012 Cavalli J, DalBó S, Bertoglio LJ, Carobrez AP. P.1.d.001 Interoceptive olfactory fear conditioning acquisition and expression is affected by a glucocorticoid agonist European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70260-2  0.313
2011 Gazarini L, Stern CA, Bertoglio LJ. Protein synthesis in dorsal hippocampus supports the drug tolerance induced by prior elevated plus-maze experience. Neuroscience. 179: 179-87. PMID 21284953 DOI: 10.1016/J.Neuroscience.2011.01.057  0.524
2010 Canteras NS, Resstel LB, Bertoglio LJ, Carobrez Ade P, Guimarães FS. Neuroanatomy of anxiety. Current Topics in Behavioral Neurosciences. 2: 77-96. PMID 21309107 DOI: 10.1007/7854_2009_7  0.378
2010 Stern CA, Do Monte FH, Gazarini L, Carobrez AP, Bertoglio LJ. Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest. Neuroscience. 170: 214-22. PMID 20620194 DOI: 10.1016/J.Neuroscience.2010.06.080  0.737
2010 Stern C, Do-Monte F, Gazarini L, Carobrez A, Bertoglio L. P.4.b.016 Ventromedial prefrontal cortex activity is required for anxiety expression: distinct neurochemical mechanisms evidence European Neuropsychopharmacology. 20: S538-S539. DOI: 10.1016/S0924-977X(10)70809-9  0.384
2009 Cavalli J, Bertoglio LJ, Carobrez AP. Pentylenetetrazole as an unconditioned stimulus for olfactory and contextual fear conditioning in rats. Neurobiology of Learning and Memory. 92: 512-8. PMID 19576288 DOI: 10.1016/J.Nlm.2009.06.010  0.34
2009 Bertoglio LJ, Monte FHMD, Aguiar AS, Santos CJPA, Silva RS. P.4.d.004 Bilateral infusion of capsazepine in the rat hippocampus: effects on anxiety and spatial learning/memory European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70982-4  0.485
2008 Moraes CL, Bertoglio LJ, Carobrez AP. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze. Behavioural Brain Research. 194: 181-6. PMID 18675851 DOI: 10.1016/J.Bbr.2008.07.005  0.355
2008 Santos CJ, Stern CA, Bertoglio LJ. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus. Behavioural Pharmacology. 19: 357-60. PMID 18622185 DOI: 10.1097/Fbp.0B013E3283095234  0.393
2008 Stern CA, Carobrez AP, Bertoglio LJ. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze. Pharmacology, Biochemistry, and Behavior. 90: 545-50. PMID 18533241 DOI: 10.1016/J.Pbb.2008.04.013  0.365
2008 Bertoglio LJ, Santos CJPA, Stern CAJ, Martins MA. P.4.b.001 Role of transient receptor potential vanilloid type 1 channels in brain regions related to anxiety in rats European Neuropsychopharmacology. 18. DOI: 10.1016/S0924-977X(08)70727-2  0.334
2007 Bertoglio LJ, Bortoli VCd, Zangrossi H. Cholecystokinin-2 receptors modulate freezing and escape behaviors evoked by the electrical stimulation of the rat dorsolateral periaqueductal gray. Brain Research. 1156: 133-138. PMID 17498673 DOI: 10.1016/J.Brainres.2007.04.038  0.388
2007 Bertoglio LJ, Bortoli VCD, Zangrossi H. P.4.b.005 Attenuation of panic-related behaviors after cholecystokinin type 2 receptor antagonism in the rat periaqueductal gray European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70789-7  0.338
2006 Bertoglio LJ, Zangrossi H. Involvement of dorsolateral periaqueductal gray N-methyl-D-aspartic acid glutamate receptors in the regulation of risk assessment and inhibitory avoidance behaviors in the rat elevated T-maze. Behavioural Pharmacology. 17: 589-596. PMID 17021391 DOI: 10.1097/01.Fbp.0000236270.64676.B4  0.33
2006 Bertoglio LJ, Joca SR, Guimarães FS. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behavioural Brain Research. 175: 183-8. PMID 16996146 DOI: 10.1016/J.Bbr.2006.08.021  0.506
2006 Bertoglio LJ, Guimarães FS, Zangrossi H. Lack of interaction between NMDA and cholecystokinin-2 receptor-mediated neurotransmission in the dorsolateral periaqueductal gray in the regulation of rat defensive behaviors. Life Sciences. 79: 2238-44. PMID 16914165 DOI: 10.1016/J.Lfs.2006.07.022  0.371
2005 Bertoglio LJ, Zangrossi H. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats. Brain Research. 1059: 46-51. PMID 16168394 DOI: 10.1016/J.Brainres.2005.08.006  0.399
2005 Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neuroscience and Biobehavioral Reviews. 29: 1193-205. PMID 16084592 DOI: 10.1016/J.Neubiorev.2005.04.017  0.313
2005 Bertoglio LJ, Anzini C, Lino-de-Oliveira C, Carobrez AP. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats. Behavioural Brain Research. 162: 99-107. PMID 15922070 DOI: 10.1016/J.Bbr.2005.03.010  0.368
2004 Bertoglio LJ, Carobrez AP. Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behavioural Pharmacology. 15: 45-54. PMID 15075626 DOI: 10.1097/00008877-200402000-00006  0.324
2003 Bertoglio LJ, Carobrez AP. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology. 170: 335-42. PMID 13680083 DOI: 10.1007/S00213-003-1558-Z  0.349
2002 Bertoglio LJ, Carobrez AP. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacology, Biochemistry, and Behavior. 73: 963-9. PMID 12213543 DOI: 10.1016/S0091-3057(02)00958-9  0.359
2002 Bertoglio LJ, Carobrez AP. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacology, Biochemistry, and Behavior. 72: 449-55. PMID 11900819 DOI: 10.1016/S0091-3057(02)00710-4  0.357
2000 Bertoglio LJ, Carobrez AP. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behavioural Brain Research. 108: 197-203. PMID 10701663 DOI: 10.1016/S0166-4328(99)00148-5  0.356
Show low-probability matches.